Chan Mitchell
Insider CIK 1789335 · AVTX Director · RGNX Chief Financial Officer · VIE Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RGNX REGENXBIO Inc. | F Tax w/h | 2026-09-01 | 2026-09-03 | 4,902 | $9.32 | $45.7K | 122,815 | SEC↗ |
| RGNX REGENXBIO Inc. | F Tax w/h | 2026-09-01 | 2026-09-03 | 4,902 | $9.32 | $45.7K | 122,815 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2026-05-06 | 2026-05-07 | 3,167 | $22.88 | $72.5K | 3,166 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-03-28 | 2026-03-31 | 3,166 | — | $0 | 3,167 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-03-28 | 2026-03-31 | 3,166 | — | $0 | 6,333 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2026-01-06 | 2026-01-08 | 39,650 | — | $0 | 39,650 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award | 2026-01-06 | 2026-01-08 | 73,749 | — | $0 | 127,717 | SEC↗ |
| RGNX REGENXBIO Inc. | F Tax w/h | 2025-09-01 | 2025-09-03 | 4,901 | $8.93 | $43.8K | 53,968 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 6,333 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 3,167 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2025-01-02 | 2025-01-06 | 62,547 | — | $0 | 62,547 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2024-09-16 | 2024-09-18 | 289,362 | — | $0 | 289,362 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award | 2024-09-16 | 2024-09-18 | 58,869 | — | $0 | 58,869 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2024-08-13 | 2024-08-14 | 9,500 | — | $0 | 9,500 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2024-08-13 | 2024-08-14 | 24,600 | — | $0 | 24,600 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2023-12-20 | 2023-12-21 | 3,334 | — | $0 | 3,334 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2022-06-14 | 2022-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AVTX | A Award deriv | 2021-12-01 | 2021-12-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| VIE Viela Bio, Inc. | D To issuer deriv | 2021-03-15 | 2021-03-15 | 50,056 | — | $0 | 0 | SEC↗ |
| VIE Viela Bio, Inc. | D To issuer deriv | 2021-03-15 | 2021-03-15 | 13,000 | — | $0 | 0 | SEC↗ |
| VIE Viela Bio, Inc. | D To issuer deriv | 2021-03-15 | 2021-03-15 | 30,000 | — | $0 | 0 | SEC↗ |
| VIE Viela Bio, Inc. | D To issuer deriv | 2021-03-15 | 2021-03-15 | 67,500 | — | $0 | 0 | SEC↗ |
| VIE Viela Bio, Inc. | D To issuer | 2021-03-13 | 2021-03-15 | 37,500 | $53.00 | $1.99M | 0 | SEC↗ |
| VIE Viela Bio, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 50,056 | — | $0 | 50,056 | SEC↗ |